John Beutler

Dr. John Beutler

National Cancer Institute at Frederick
orcid

Biography

Dr. Beutler has identified several natural products which have potential for development as cancer drugs, among them, englerins, which are in preclinical development for kidney cancer and Ewing’s sarcoma, schweinfurthins, which are preclinical candidates in glioblastoma and malignant peripheral nerve sheath tumors, and salicylihalamides, of interest in sarcomas. As a Staff Scientist 2, Dr. Beutler oversees the Program's high-throughput screening libraries, information technology, and drug development efforts.

Affiliations

No affiliation has been shared yet.

Honors and Awards

honor

AAAS Fellow

American Association for the Advancement of Science

Experience

Others

Molecular Diversity Preservation International

01 May 1998 - present

Senior Scientist or Principal Investigator

National Cancer Institute

01 Apr 1984 - present

Post Doctoral Researcher

University of Texas Medical School, Houston

01 Oct 1983 - 01 Apr 1984

University Educator/Researcher

Auburn University School of Pharmacy

01 Oct 1981 - 01 Jun 1983

Post Doctoral Researcher

Northeastern University Department of Chemistry

01 Sep 1980 - 01 Aug 1981

Graduate Student or Post Graduate

University of the Sciences in Philadelphia

01 Sep 1975 - 01 Jun 1980

Undergraduate Student

Vassar College

01 Sep 1970 - 01 Jun 1972

Undergraduate Student

Lehigh University

01 Sep 1968 - 01 Jun 1970